Clinical Trials Browser

Completed × Cardiovascular Diseases × 90 days × Clear all

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus

NCT07443787 2026-03-02

Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy

Phase NA Completed

150 enrolled

Cardiovascular Diseases, Motor Activity

NCT01633021 2026-02-20

Developing the Family Map: Looking at Communal Coping

Completed

1,061 enrolled

Classical hematology

Anemia, Sickle Cell, Cardiovascular Diseases, Diabetes Mellitus, Neoplasms, Sickle Cell Trait

NCT05228470 2026-01-06

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Phase 2 Completed

39 enrolled 15 charts

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT01671696 2026-01-02

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

Completed

80 enrolled

Cardiovascular Diseases

NCT04657120 2025-12-23

HYDRA

Phase NA Completed

698 enrolled

Cardiovascular Diseases, Disease, Embolism, Lung Diseases, Neoplasms, Pulmonary Embolism, Respiratory Tract Diseases, Vascular Diseases, Embolism and Thrombosis

Clinical Trials

Risk Communication Within Mexican-American Families

Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy

Developing the Family Map: Looking at Communal Coping

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy

HYDRA